Antibody Persistence after Serogroup C Meningococcal Conjugate Immunization of United Kingdom Primary‐School Children in 1999–2000 and Response to a Booster: A Phase 4 Clinical Trial

This publication has 11 references indexed in Scilit:

• Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine
  Clinical and Vaccine Immunology, 2010
• Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine
  Vaccine, 2009
• B-cell responses to vaccination at the extremes of age
  Nature Reviews Immunology, 2009
• Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines
  Nature Reviews Immunology, 2009
• Seroprevalence of Antibodies against Serogroup C Meningococci in England in the Postvaccination Era
  Clinical and Vaccine Immunology, 2008
• Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study
  BMJ, 2008
• Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
  The Journal of Infectious Diseases, 2008
• Vaccinating adolescents against meningococcal disease in Canada: A cost-effectiveness analysis
  Vaccine, 2007
• Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: A model-based evaluation
  Vaccine, 2006
• Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in England
  Clinical and Vaccine Immunology, 2003